Diabetes and Peripheral Vascular Disease (PVD) continue to be a growing epidemic globally, universally placing enormous economic toll on national healthcare systems. With new emerging medical technologies like MIMOSA Pro, however, there is the potential to diagnosis & treat these conditions much earlier before the development of detrimental complications.Get A Demo
Most patients with diabetic foot ulcers (DFUs) and poorly healing lower extremity wounds should also undergo a thorough noninvasive vascular evaluation. But yet again, this often does not occur prior to more catastrophic consequences like a foot wound or amputation. A simple physical exam and palpable pedal pulse assessment are usually adequate to ensure pedal blood flow but seldom are performed prior to complications arising.
When it comes to most lower extremity wounds, the use of appropriate wound care and adequate revascularization should facilitate significant progress toward healing in three to four weeks. If this does not occur, it is essential to obtain a formal vascular consultation with at least an ankle brachial index (ABI) and a duplex arterial ultrasound being included. However, patients with advanced vascular complications can have false or spurious results, so these techniques are not full proof and a more comprehensive assessment should be considered. Such rigorous vascular assessment is more appropriate at an earlier stage to prevent complications arising in the first place.
MIMOSA Pro is a handheld device that uses near-infrared light to accurately and non-invasively assess tissue health. It can be easily used by a patient or a caregiver, and the images produced will help inform the next steps within patient navigation and management (e.g. you need to see a podiatrist, or a vascular surgeon to help with the blood flow, or you may need more urgent treatment to prevent severe complications like limb loss). One significant area where vascular assessment can have significant clinical impact is in the management of patient with diabetes.
With more accurate monitoring and early diagnosis, patients are getting better treatment, and as a result the amputation rates can be reduced dramatically. Not only can this approach save limbs, but rather lives.
Diabetes is one area of vascular medicine where MIMOSA Pro can help. There are similar compromised vascular diseases where such an approach can make a huge difference. So, this emerging assessment and diagnostic tool will have huge impact in the management of patients with compromised vasculature. MIMOSA Pro is going to change the way in which many of these patients are managed.
This pocket-sized device can be used by any healthcare professional to collect and collate data for clinician review - allowing for a reduction in workload for the clinician and unprecedented access to care for patients!Get a Demo